Pakistan’s Drug Regulatory Authority (DRAP) is facing pressure to exempt 10cc syringes from a recent ban implemented following a spike in HIV cases. The ban, intended to curb unsafe medical practices, has inadvertently created shortages impacting various medical procedures. Healthcare professionals argue the 10cc syringes remain vital for specific treatments, including surgeries and certain vaccinations, and are not directly linked to the HIV transmission incidents. The Sindh AIDS Control Programme highlighted the ban’s detrimental effects on HIV-affected patients requiring regular treatment. Concerns are growing that the continued ban will hinder essential healthcare services and potentially endanger patient lives. DRAP is currently reviewing the situation and considering the appeals for exemption, balancing public health safety with the necessary availability of medical supplies. A final decision is expected soon to address the critical shortage and its potential repercussions.